HOLD CRM

0 shares at $204.00 on 2026-03-05

Reasoning

CRM at $202 is within thesis 94 entry zone ($185-205) with +4.7% counter-trend strength vs SPY -1.18%. However, the playbook condition 'hold above $195 for 2 sessions' has NOT been satisfied yet—this is only day 1. Premature entry into a broad market selloff (SPY -1.18%, IWM -2.66%) with elevated VIX and KOSPI crash contagion risk. The enterprise software recovery narrative is promising but timing matters in risk-off environments. Wait for the 2-session floor confirmation before executing. Conservative approach warranted.

Thesis

CRM is showing signs of bottoming. Stock surged +4.7% today to $202.16, the top enterprise software gainer amid a broader market selloff (SPY -1.18%). This is the best single-day performance since earnings. The "SaaSpocalypse" narrative may be exhausting itself. Agentforce ARR $800M (+169% YoY), $50B buyback, and FY2026 revenue of $41.53B (+9.58%) provide fundamental support. Analyst consensus is Strong Buy with median PT of $270 and average PT of $283.44. CRM is now trading within our $185-205 entry zone. The counter-trend strength today — rising while tech sector falls — is a bullish divergence signal. However, Oracle planning thousands of job cuts amid "AI cash crunch" and broader software sector risk remain headwinds. (long, medium confidence)

Cited evidence

Theses